CRP

CRP
Name	C-reactive protein
Uniprot	P02741
Gene	CRP
Organism	Human

CRP C-reactive protein is an acute-phase plasma protein synthesized primarily in the liver that rises rapidly in response to inflammation, infection, and tissue injury. It serves as a biomarker in clinical practice and is central to studies linking innate immunity with cardiovascular disease, infectious diseases, and rheumatologic conditions. Research on C-reactive protein spans molecular biology, epidemiology, and translational medicine.

Overview

C-reactive protein was first described during studies of the Pneumococcal pneumonia capsular polysaccharide and later characterized in investigations involving Emil von Behring, Paul Ehrlich, and the development of serologic reagents; its discovery influenced work at institutions such as the Rockefeller Institute and the Pasteur Institute. CRP is a member of the pentraxin family related to proteins studied by investigators at Harvard Medical School and Johns Hopkins University, and it features in landmark cohort studies like the Framingham Heart Study and the Nurses’ Health Study. Epidemiologic links have been explored in consortia including the INTERHEART and Global Burden of Disease collaborations.

Structure and Biochemistry

The protein is a pentameric molecule composed of five identical subunits, each encoded by a gene located on chromosome 1 and sequenced in laboratories affiliated with Wellcome Trust Sanger Institute and National Institutes of Health. Structural determination by X-ray crystallography involved groups at MRC Laboratory of Molecular Biology and revealed calcium-dependent ligand binding similar to other pentraxins such as Serum amyloid P component. Post-translational modifications and isoforms have been examined in proteomics centers at Massachusetts Institute of Technology and European Molecular Biology Laboratory, while evolutionary comparisons draw on genomic data from the 1000 Genomes Project and the Human Genome Project.

Clinical Significance and Diagnostic Use

Clinically, CRP measurement is used across specialties including cardiology at centers like Mayo Clinic, infectious disease at Centers for Disease Control and Prevention, and rheumatology at Cleveland Clinic. High-sensitivity CRP assays inform risk stratification in cardiovascular cohorts analyzed in the Atherosclerosis Risk in Communities Study and trials such as JUPITER and PROVE-IT TIMI 22. In infectious disease outbreaks cataloged by World Health Organization reports, CRP assists in distinguishing bacterial from viral etiologies alongside biomarkers evaluated by European Centre for Disease Prevention and Control. Rheumatologic activity indices developed at institutions like University College London and Karolinska Institute incorporate CRP for disease monitoring.

Measurement Methods

Assay development has involved manufacturers and laboratories including Roche Diagnostics, Abbott Laboratories, and academic labs at University of Oxford. Conventional CRP assays (nephelometry, turbidimetry) and high-sensitivity immunoassays used in trials such as JUPITER were standardized in reference laboratories including National Institute of Standards and Technology and Centers for Disease Control and Prevention. Point-of-care lateral flow tests evaluated by teams at Imperial College London and Stanford University enable rapid assessment in settings like emergency departments at Mount Sinai Health System. Mass spectrometry platforms developed at Max Planck Institute and Scripps Research provide proteoform resolution for research applications.

Biological Function and Pathophysiology

Functionally, the protein participates in opsonization and activation of the classical complement pathway via interactions characterized in studies at Rockefeller University and Institut Pasteur. It binds phosphocholine on microbial surfaces as demonstrated in experiments by researchers affiliated with Cold Spring Harbor Laboratory and modulates macrophage and neutrophil responses in models developed at Fred Hutchinson Cancer Research Center and Dana-Farber Cancer Institute. Pathophysiologic roles have been implicated in atherogenesis examined in INTERHEART and mechanistic work at Stanford University School of Medicine, where links to endothelial dysfunction, plaque instability, and thrombosis were explored. Genetic association studies from consortia such as the International HapMap Project and UK Biobank have clarified causal relationships and confounding in disease associations.

Therapeutic and Research Applications

CRP is targeted indirectly in therapeutic strategies evaluated in randomized trials at institutions like Brigham and Women’s Hospital and Cleveland Clinic that tested anti-inflammatory agents including inhibitors assessed in the CANTOS and CIRT trials. Monoclonal antibody development and small-molecule inhibitors have been pursued in industry programs at Genentech and Pfizer as well as academic spinouts from University of Pennsylvania. In translational research, CRP is used as an endpoint in vaccine trials coordinated by Gavi, the Vaccine Alliance and Coalition for Epidemic Preparedness Innovations, and as a biomarker in precision-medicine initiatives at Broad Institute and Wellcome Sanger Institute. Advanced methodologies in systems biology from EMBL-EBI and Cold Spring Harbor Laboratory continue to refine its role in host defense and chronic disease.

Category:Acute-phase proteins